Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million
07/05/2026 07:53
May 7 (Reuters) - Active Biotech AB publ ACTI.ST: REPORTS LOSS AFTER TAX OF SEK 8.4 MILLION FOR JAN-MAR 2026 CASH AND CASH EQUIVALENTS SEK 53.3 MILLION AT END OF JAN-MAR 2026 Source text: ID:nMFN33hVsX Further company coverage: ACTI.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million